Variant report

Variant	nsv1034194
Chromosome Location	chr5:50209649-50234259
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr5:50225129-50225484	K562	blood:	n/a	n/a
2	BHLHE40	chr5:50218597-50218768	K562	blood:	n/a	n/a
3	CEBPB	chr5:50225036-50225368	A549	lung:	n/a	chr5:50225195-50225206
4	CEBPB	chr5:50222809-50223072	HepG2	liver:	n/a	chr5:50222984-50222995
5	CEBPB	chr5:50225040-50225385	HepG2	liver:	n/a	chr5:50225195-50225206
6	CEBPB	chr5:50225112-50225366	H1-hESC	embryonic stem cell:	n/a	chr5:50225195-50225206
7	CEBPB	chr5:50225028-50225380	Hela-S3	cervix:	n/a	chr5:50225195-50225206
8	CEBPB	chr5:50222836-50223100	IMR90	lung:	n/a	chr5:50222984-50222995
9	CEBPB	chr5:50225041-50225353	K562	blood:	n/a	chr5:50225195-50225206
10	CEBPB	chr5:50222863-50223092	A549	lung:	n/a	chr5:50222984-50222995
11	CEBPB	chr5:50224895-50225453	HCT-116	colon:	n/a	chr5:50225195-50225206
12	CEBPB	chr5:50225041-50225372	IMR90	lung:	n/a	chr5:50225195-50225206
13	CEBPB	chr5:50222898-50223030	K562	blood:	n/a	chr5:50222984-50222995
14	CTCF	chr5:50218560-50218710	GM12872	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
15	CTCF	chr5:50218520-50218670	HRPEpiC	eye:	n/a	n/a
16	CTCF	chr5:50218580-50218730	NB4	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
17	CTCF	chr5:50218556-50218777	Lung_OC	lung:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
18	CTCF	chr5:50218580-50218730	HepG2	liver:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
19	CTCF	chr5:50218439-50218864	K562	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
20	CTCF	chr5:50218455-50218840	K562	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
21	CTCF	chr5:50218540-50218690	AG04449	skin:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
22	CTCF	chr5:50218605-50218805	IMR90	lung:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
23	CTCF	chr5:50218580-50218730	GM12874	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
24	CTCF	chr5:50218540-50218690	GM12864	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
25	CTCF	chr5:50218518-50218790	GM20000	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
26	CTCF	chr5:50218600-50218750	GM12866	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
27	CTCF	chr5:50218481-50218798	K562	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
28	CTCF	chr5:50218580-50218730	GM12870	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
29	CTCF	chr5:50218560-50218710	GM06990	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
30	CTCF	chr5:50218516-50218800	GM12878	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
31	CTCF	chr5:50218800-50218950	NHLF	lung:	n/a	n/a
32	CTCF	chr5:50218515-50218787	ProgFib	skin:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
33	CTCF	chr5:50218484-50218846	K562	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
34	CTCF	chr5:50218518-50218815	GM10266	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
35	CTCF	chr5:50218464-50218804	GM12891	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
36	CTCF	chr5:50218580-50218730	BE2_C	brain:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
37	CTCF	chr5:50218481-50218802	Gliobla	brain:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
38	CTCF	chr5:50218560-50218710	GM12869	blood:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
39	CTCF	chr5:50218600-50218750	NHDF-neo	bronchial:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
40	CTCF	chr5:50218600-50218750	HVMF	connective:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
41	CTCF	chr5:50218700-50218850	AG04450	lung:	n/a	n/a
42	CTCF	chr5:50218580-50218730	SAEC	small airway:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
43	CTCF	chr5:50218532-50218790	Pancreas_OC	pancreas:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
44	CTCF	chr5:50218740-50218890	HEK293	kidney:	n/a	n/a
45	CTCF	chr5:50218580-50218730	WERI-Rb-1	eye:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
46	CTCF	chr5:50218600-50218750	HCT-116	colon:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
47	CTCF	chr5:50218649-50218750	LNCaP	prostate:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
48	CTCF	chr5:50218440-50218590	HFF-Myc	foreskin:	n/a	n/a
49	CTCF	chr5:50218503-50218786	MCF-7	breast:	n/a	chr5:50218664-50218682 chr5:50218667-50218676
50	CTCF	chr5:50218516-50218786	Spleen_OC	spleen:	n/a	chr5:50218664-50218682 chr5:50218667-50218676

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:50218625-50218675	AG09309	skin:	n/a
2	chr5:50218625-50218675	AG09309	skin:	n/a
3	chr5:50219227-50219277	AG04449	skin:	fetal
4	chr5:50218876-50218926	BJ	skin:	n/a
5	chr5:50218625-50218675	HEK293	kidney:	embryo
6	chr5:50218876-50218926	HCM	heart:	n/a
7	chr5:50218876-50218926	AG04450	lung:	fetal
8	chr5:50219072-50219122	H1-hESC	embryonic stem cell:	embryo
9	chr5:50219467-50219517	NH-A	brain:	n/a
10	chr5:50218876-50218926	AG10803	skin:	n/a
11	chr5:50219467-50219517	HCF	heart:	n/a
12	chr5:50219467-50219517	HL-60	blood:	n/a
13	chr5:50218625-50218675	HMEC	breast:	n/a
14	chr5:50218876-50218926	RPTEC	kidney:	n/a
15	chr5:50218625-50218675	HCM	heart:	n/a
16	chr5:50218876-50218926	HRCEpiC	kidney:	n/a
17	chr5:50219072-50219122	HPAEpiC	pulmonary alveolar:	n/a
18	chr5:50218876-50218926	U87	brain:	n/a
19	chr5:50218876-50218926	NH-A	brain:	n/a
20	chr5:50219227-50219277	MCF-7	breast:	n/a
21	chr5:50218625-50218675	NT2-D1	testis:	n/a
22	chr5:50219467-50219517	Caco-2	colon:	n/a
23	chr5:50219227-50219277	BE2_C	brain:	n/a
24	chr5:50219072-50219122	RPTEC	kidney:	n/a
25	chr5:50218922-50218972	PFSK-1	brain:	n/a
26	chr5:50219072-50219122	HIPEpiC	eye:	n/a
27	chr5:50219467-50219517	NT2-D1	testis:	n/a
28	chr5:50219467-50219517	IMR90	lung:	fetal
29	chr5:50218922-50218972	HRCEpiC	kidney:	n/a
30	chr5:50219227-50219277	HCT-116	colon:	n/a
31	chr5:50218876-50218926	HL-60	blood:	n/a
32	chr5:50219467-50219517	HIPEpiC	eye:	n/a
33	chr5:50219467-50219517	T-47D	breast:	n/a
34	chr5:50219227-50219277	SKMC	muscle:	n/a
35	chr5:50219227-50219277	GM12891	blood:	n/a
36	chr5:50218625-50218675	HL-60	blood:	n/a
37	chr5:50218922-50218972	HCM	heart:	n/a
38	chr5:50218922-50218972	A549	lung:	n/a
39	chr5:50218876-50218926	HMEC	breast:	n/a
40	chr5:50218922-50218972	H1-hESC	embryonic stem cell:	embryo
41	chr5:50219467-50219517	NHBE	bronchial:	n/a
42	chr5:50218625-50218675	NHBE	bronchial:	n/a
43	chr5:50219072-50219122	AG04449	skin:	fetal
44	chr5:50219072-50219122	MCF-7	breast:	n/a
45	chr5:50219227-50219277	SK-N-SH_RA	brain:	n/a
46	chr5:50218922-50218972	HEEpiC	esophagus:	n/a
47	chr5:50219227-50219277	K562	blood:	n/a
48	chr5:50219467-50219517	BJ	skin:	n/a
49	chr5:50218625-50218675	HAEpiC	amniotic membrane:	n/a
50	chr5:50219072-50219122	HepG2	liver:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:50228151..50230751-chr5:50231157..50233024,2	K562	blood:
2	chr5:50227478..50230397-chr5:50232947..50234974,2	MCF-7	breast:
3	chr5:50203464..50206328-chr5:50214856..50217371,2	MCF-7	breast:
4	chr5:50215584..50218539-chr5:50219483..50221436,2	MCF-7	breast:
5	chr12:99592032..99592637-chr5:50232515..50233131,2	MCF-7	breast:
6	chr5:50215584..50218539-chr5:50219483..50221436,2	MCF-7	breast:
7	chr5:50233489..50235241-chr5:50248596..50251574,2	K562	blood:

Variant related genes	Relation type
ENSG00000251601	TF binding region
ENSG00000251601	CpG island
ENSG00000251601	chromatin interactions

Extended variants
information (count: 261 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:261 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3991897	chr5:50218065-50218066	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs3991896	chr5:50218081-50218082	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs3958408	chr5:50218109-50218110	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs574207841	chr5:50218185-50218186	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs111229654	chr5:50218208-50218209	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs55782617	chr5:50218278-50218279	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs146401703	chr5:50218305-50218306	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs889227	chr5:50218340-50218341	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs528730108	chr5:50218345-50218346	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs545366975	chr5:50218346-50218347	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs376919331	chr5:50218349-50218350	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs188075668	chr5:50218384-50218385	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs377436451	chr5:50218394-50218395	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs199752055	chr5:50218395-50218396	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs530788585	chr5:50218396-50218397	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs550975192	chr5:50218399-50218400	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs567730045	chr5:50218402-50218403	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs371006796	chr5:50218404-50218405	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs546770620	chr5:50218441-50218442	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs191292348	chr5:50218499-50218500	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs538869098	chr5:50218509-50218510	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs558558468	chr5:50218575-50218576	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs368230472	chr5:50218578-50218579	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs112206672	chr5:50218606-50218607	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs537406499	chr5:50218661-50218662	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs554151394	chr5:50218663-50218664	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs112947786	chr5:50218677-50218678	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs889218	chr5:50218729-50218730	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs539934341	chr5:50218792-50218793	Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs553491149	chr5:50218823-50218824	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs573341017	chr5:50218862-50218863	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs545610063	chr5:50218879-50218880	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs555900760	chr5:50218911-50218912	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs182617120	chr5:50219015-50219016	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs575910352	chr5:50219075-50219076	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs376647472	chr5:50219084-50219085	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs111815994	chr5:50219088-50219089	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs530165789	chr5:50219098-50219099	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs115553495	chr5:50219112-50219113	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs560606592	chr5:50219134-50219135	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs545469468	chr5:50219164-50219165	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs532188422	chr5:50219166-50219167	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs186471172	chr5:50219175-50219176	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs569013966	chr5:50219204-50219205	Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs538142850	chr5:50219226-50219227	Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs191272372	chr5:50219280-50219281	Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs113131737	chr5:50219282-50219283	Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs370304288	chr5:50219288-50219289	Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs552013232	chr5:50219292-50219293	Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs533576120	chr5:50219316-50219317	Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	17550852	CNVD
Thoracic aortic aneurysm	21092924	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Cancer	16751803	CNVD
Autism	22495311	CNVD
Intellectual disability	22102821	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Non-small cell lung cancer	21829676	CNVD
Breast cancer	22032731	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
adenomatous polyposis	22470819	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21364760	CNVD
Oral cancer	21386901	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Bladder cancer	21909424	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Acute lymphoblastic leukemia	21339820	CNVD

Chromatin state (count:25 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:50218000-50218800	Enhancers	Placenta	Placenta
2	chr5:50218000-50219200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr5:50218400-50218600	Enhancers	Fetal Muscle Leg	muscle
4	chr5:50218400-50218800	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr5:50218400-50218800	Active TSS	Stomach Smooth Muscle	stomach
6	chr5:50218400-50219000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
7	chr5:50218400-50219000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
8	chr5:50218800-50219000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr5:50218800-50219000	Flanking Active TSS	Stomach Smooth Muscle	stomach
10	chr5:50218800-50219200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr5:50218800-50219200	Enhancers	HepG2	liver
12	chr5:50218800-50219800	Weak transcription	Fetal Muscle Leg	muscle
13	chr5:50219000-50219200	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
14	chr5:50219000-50219200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
15	chr5:50219000-50219400	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr5:50219200-50219400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr5:50219200-50219400	Bivalent Enhancer	HepG2	liver
18	chr5:50219400-50219600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr5:50219600-50219800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
20	chr5:50219800-50220200	Enhancers	Fetal Muscle Trunk	muscle
21	chr5:50219800-50220200	Enhancers	Fetal Muscle Leg	muscle
22	chr5:50225000-50225400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr5:50228000-50228400	Enhancers	iPS-18 Cell Line	embryonic stem cell
24	chr5:50228000-50228400	Enhancers	iPS-20b Cell Line	embryonic stem cell
25	chr5:50228000-50228600	Enhancers	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links